Digital PCR (DPCR) and Real-Time PCR (QPCR) Market Worth $12.4 Billion : MarketsandMarkets
In October 2022, Roche received FDA clearance for the COVID-19 PCR test for use on cobas 6800/8800 systems. The cobas SARS-CoV-2 Qualitative test is one of the first COVID-19 PCR tests performed on an automated, high-throughput platform to receive FDA 510(k) clearance.
View full press release